It combines the effects of GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) , two hormones that work together to control blood sugar and appetite
doi:10.2147/CCID.S128339 Handog EB, Datuin MS, Singzon IA
Are there coverage limits (e.g., 6 months, one year, etc.)
Cela signifie que les cellules peuvent mtaboliser les nutriments plus efficacement, convertissant les glucides, les lipides et les protines en nergie utilisable
For patients who need both Toujeo specifically (the U-300 concentration) and a GLP-1 agonist, separate injections are currently the only option, as there is no combination product using the U-300 concentration